Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Edward Lifesciences Corporation (“Edwards”) (NYSE: EW) common stock between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”).
Edwards is a medical technology company that develops, manufactures, and markets devices for structural heart disease, critical care, and surgical monitoring. Edwards’ primary product is the Transcatheter Aortic Valve Replacement (“TAVR”), which is a minimally invasive alternative procedure to open-heart surgery in certain circumstances.
The Class Period begins on February 6, 2024, when Edwards issued its fourth quarter results. In connection with its results, the company published a press release, highlighting, in pertinent part, the significant progress that was made by the TAVR - stating that “Q4 TAVR sales grew 13 percent; constant currency sales grew 12 percent.”
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) TAVR volume had started declining as early as 2023; (2) TAVR sales growth was limited at least in part due to hospital capacity constraints; (3) hospitals were dedicating their limited resources to more time and cost efficient procedures other than the TAVR; and (4) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Current Status of Case:
On October 21, 2025, Defendants filed an Answer to the Amended Complaint. This action is in the discovery phase and is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.